artemisone
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT00936767)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- artemisone
- artemisone
- artemisone
- bay 44-9585
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00936767 | Phase 2/Phase 3 (Phase 3) | Oct 1, 2010 | Cambodia National Malaria Control Programme, Mahidol University, Medicines for Malaria Venture, University of Oxford |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cambodia National Malaria Control Programme | Government | 1 | 0 | 1 | 2010 |
| Mahidol University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Medicines for Malaria Venture | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2010 |
4 organizations
Page 1 / 1